50 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
.
We may fail to achieve our projected development goals in the time frames we announce and expect.
Any drug delivery device used may have its own … development goals in the time frames we announce and expect, the commercialization of our product candidates may be delayed and our expenses may increase
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
development goals in the time frames we announce and expect.
Any drug delivery device used may have its own regulatory development, supply, and other … , or are significantly delayed in doing so, our business will be materially harmed.
If we do not achieve our projected development goals in the time frames we announce
POS AM
xkd5z64dmy5
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
S-8
EX-99.1
zqs z0nvw
22 Dec 23
Registration of securities for employees
5:00pm
S-8
EX-99.2
up2rjv zzgdy
22 Dec 23
Registration of securities for employees
5:00pm
8-K
EX-99.1
o9e56
24 Oct 23
Regulation FD Disclosure
9:00am